Martin Leach

Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH.

Pollen, Inc. provides financial services. It provides C2FO market, working capital exchange that allows companies to optimize their working capital positions in a live, bid/ask environment. The firm serves buyers and suppliers who use the market to increase profit and accelerate cash flow between themselves. The company was founded by Alexander C. Kemper and Pete Thomas in May 2010 and is headquartered in Leawood, KS.

AppDirect, Inc. develops end-to-end commerce platform for selling, distributing, and managing cloud-based products and services. It offers AppMarket, AppReseller, AppBilling, and AppDistribution. The company was founded by Nicolas Desmarais, Andy Sen, and Daniel H. Saks in 2009 and is headquartered in San Francisco, CA.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

Helion Energy, Inc. manufactures power generation technology. It develops power plants that would produce electricity by running a nuclear-fusion reaction whereby atoms merge at extremely high temperatures. The company was founded by David Kirtley, John Slough, Chris Pihl and George Votroubek in 2009 and is headquartered in Redmond, WA.

Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Mubadala Capital (Mubadala Capital) is a private equity subsidiary of Mubadala Investment Co. PJSC founded in 2011. The firm is headquartered in Abu Dhabi, United Arab Emirates with offices in London, New York, Rio De Janeiro, and San Francisco.

Formation8 Partners LLC (Formation8) is a venture capital firm founded in 2011 by Joe Lonsdale, Brian Koo, and Jim Kim. The firm is headquartered in San Francisco, California.

SigFig Wealth Management LLC (SigFig) is a SEC-registered financial advisor headquartered in San Francisco, California. The firm was co-founded by Michael Sha in 2011 and is a wholly owned subsidiary of Nvest, Inc. SigFig provides a free portfolio tracking service to individuals by allowing them to link their external brokerage accounts to SigFig’s web-based platform. The firm also provides discretionary investment advisory and portfolio management services to individuals who open an investment management account.

Flare Capital Management Co LLC (Flare Capital Management) is a venture capital firm founded in 2000 by Bill Geary and Michael Greeley. The firm is headquartered in Boston, Massachusetts.

ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel.

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Invicta Medical, Inc. operates as a medical technology company that develops wearable device for treatment of sleep apnea and snoring. Its device detects and treats disturbed breathing through electrical stimulation. The company was founded by Steven T. Kent and Harold Kent in 2013 and is headquartered in Portola Valley, CA.

Innovaccer, Inc. develops and delivers analytical and data science applications. The firm?s products include InCare, InNote, InGraph, InConnect and InAPI. Its solutions include ACO management, patient engagement, SDOH management, referral management, web interface reporting, PCMH, pediatric population health management and outreach management. The company was founded by Sandeep Gupta, Kanav Hasija, and Abhinav Shashank in 2014 and is headquartered in San Francisco, CA.

Orca Biosystems, Inc. engages in empowering cell therapies by precisely engineering bone marrow transplants (BMT) using rapid clinical cell sorting of human grafts. The company was founded by Nathaniel fernhoff and Ivan K. Dimov and is headquartered in Mountain View, CA.

Upstream Research, Inc. operates data-driven prospecting platform. It offers upstream reports that reveal historic and present environmental risk drivers, EPA toxic release reports, available water data, and disease rates for any area. The company was founded by Nick Bedbury, John Ballantine, Scott Bedbury, and Alex Philp on August 12, 2015 and is headquartered in Bainbridge Island, WA.

Angiex, Inc. operates as a biotechnology company, which engages in the development of an antibody-drug conjugate therapy for cancer. It focuses on TM4SF1, a membrane glycoprotein of tetraspanin topology that was originally discovered as a protein expressed on many human epithelial tumor cells. The company was founded by Paul Jaminet, Harold Dvorak, and Shou-Ching Jaminet in 2015 and is headquartered in Cambridge, MA.

Mubadala Ventures is a venture capital arm founded in 2017. the firm is headquartered in San Francisco, United States. the firm is a subsidiary of Mubadala Investment Co. additional offices in Abu Dhabi, New York, San Francisco, London, and Rio de Janeiro.

ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany.

Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.

Presight Capital Management Co LLC (Presight Capital) is a venture capital subsidiary of Apeiron Investment Group Ltd founded in 2019 by Christian Angermayer and Fabian Hansen. The firm is headquartered in West Hollywood, California.

Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA.

Xilis, Inc. engages in the development of droplet-based microfluidics technology devices for precision cancer diagnostics and drug development. It offers Xilis platform. The company was founded by Xiling Shen and David Shu and is headquartered in Durham, NC.

Astra Space, Inc. is a technology company that provides space services, including satellite launch services and other space services, based on a proprietary, vertically-integrated technology platform. The company was founded by Chris Kemp and Adam London in September 2016 and is headquartered in Alameda, CA.

Wellpay Corp. operates a financial technology platform. The firm offers secure payment and financing solutions for all healthcare practice types. The company was founded by Mohammad Gaber, Noha Carrington and Jonathan Eng in February 2019 and is headquartered in San Mateo, CA.

Pango, Inc. develops privacy and security products. It offers hotspot shield, 1password, robo shield, and identity guard. The company was founded by Sujay Jaswa in 2018 and is headquartered in Redwood City, CA.

Part of Razor Group GmbH, Grupo Valoreo SA de CV is a next-gen consumer and e-commerce holding Mexican company. The company is based in Ciudad de Mexico, Mexico. The company has raised capital from some of the world's leading investment firms such as Upper90, FJ Labs, Angel Ventures, and Presight Capital, as well as prominent angel investors. The company was founded by Miguel Oehling, Cedrik Hoffmann, Stefan Florea, Alexander Gruell, Martin Florea, and Stefan Florea, Alexander Gruell, Martin Florea have been the CEOs since incorporation. Grupo Valoreo SA de was acquired by Razor Group GmbH on December 22, 2022.

Pretzel Therapeutics, Inc. is an American biotechnology company that develops therapies by utilizing mitochondrial biology. Pretzel Therapeutics is based in an undisclosed location and has research facilities in another undisclosed location. The company aims to develop treatments that address the genetic causes of mitochondrial dysfunction. The company was founded by academic experts in mitochondrial biology and is supported by a world-class investor syndicate. Jay Parrish has been the CEO of the company since 2021.

The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA.